ChinaBulls

Jiangsu Sihuan Bioengineering Co., Ltd.四环生物

Venture Capital2 recorded investments

Jiangsu Sihuan Bioengineering is the Shenzhen-listed company with stock code 000518. In September 2026 it announced a proposed RMB160 million acquisition of 65.6146% of Zhongrun Pharmaceutical.

Source: ChinaBulls — chinabulls.com

Last updated 2026-10-01

Recorded Investments

  • Investment detailsInvestment dates require an account.
    RaisedFunding amount requires an account.

    Create Account to Unlock Full Data for Free

    SIGN UP

Jiangsu Sihuan Bioengineering Co., Ltd. Investment Info

Investor investment information requires an account.

Jiangsu Sihuan Bioengineering Co., Ltd. Portfolio Companies

Unlock Full Data for Free

Get access to market data, insights, backers, analytics and funding rounds.

SIGN UP